405 related articles for article (PubMed ID: 33692132)
1. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.
Kumthekar P; Ko CH; Paunesku T; Dixit K; Sonabend AM; Bloch O; Tate M; Schwartz M; Zuckerman L; Lezon R; Lukas RV; Jovanovic B; McCortney K; Colman H; Chen S; Lai B; Antipova O; Deng J; Li L; Tommasini-Ghelfi S; Hurley LA; Unruh D; Sharma NV; Kandpal M; Kouri FM; Davuluri RV; Brat DJ; Muzzio M; Glass M; Vijayakumar V; Heidel J; Giles FJ; Adams AK; James CD; Woloschak GE; Horbinski C; Stegh AH
Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692132
[TBL] [Abstract][Full Text] [Related]
2. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
[TBL] [Abstract][Full Text] [Related]
3. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
[TBL] [Abstract][Full Text] [Related]
4. Dual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo.
Sita TL; Kouri FM; Hurley LA; Merkel TJ; Chalastanis A; May JL; Ghelfi ST; Cole LE; Cayton TC; Barnaby SN; Sprangers AJ; Savalia N; James CD; Lee A; Mirkin CA; Stegh AH
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4129-4134. PubMed ID: 28373576
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Physicochemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma.
Tommasini-Ghelfi S; Lee A; Mirkin CA; Stegh AH
Methods Mol Biol; 2019; 1974():371-391. PubMed ID: 31099015
[TBL] [Abstract][Full Text] [Related]
6. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.
Kouri FM; Hurley LA; Daniel WL; Day ES; Hua Y; Hao L; Peng CY; Merkel TJ; Queisser MA; Ritner C; Zhang H; James CD; Sznajder JI; Chin L; Giljohann DA; Kessler JA; Peter ME; Mirkin CA; Stegh AH
Genes Dev; 2015 Apr; 29(7):732-45. PubMed ID: 25838542
[TBL] [Abstract][Full Text] [Related]
7. Spherical Nucleic Acids as Precision Therapeutics for the Treatment of Cancer-From Bench to Bedside.
Mahajan AS; Stegh AH
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406387
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Behavior of Ultrasmall Spherical Nucleic Acids.
Callmann CE; Vasher MK; Das A; Kusmierz CD; Mirkin CA
Small; 2023 Jun; 19(24):e2300097. PubMed ID: 36905236
[TBL] [Abstract][Full Text] [Related]
9. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
[TBL] [Abstract][Full Text] [Related]
10. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
Geletneky K; Huesing J; Rommelaere J; Schlehofer JR; Leuchs B; Dahm M; Krebs O; von Knebel Doeberitz M; Huber B; Hajda J
BMC Cancer; 2012 Mar; 12():99. PubMed ID: 22436661
[TBL] [Abstract][Full Text] [Related]
11. miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics.
Kouri FM; Ritner C; Stegh AH
Cell Cycle; 2015; 14(24):3794-800. PubMed ID: 26506113
[TBL] [Abstract][Full Text] [Related]
12. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
13. Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.
Stegh AH; Kim H; Bachoo RM; Forloney KL; Zhang J; Schulze H; Park K; Hannon GJ; Yuan J; Louis DN; DePinho RA; Chin L
Genes Dev; 2007 Jan; 21(1):98-111. PubMed ID: 17210792
[TBL] [Abstract][Full Text] [Related]
14. Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.
Kapadia CH; Melamed JR; Day ES
BioDrugs; 2018 Aug; 32(4):297-309. PubMed ID: 29959665
[TBL] [Abstract][Full Text] [Related]
15. Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial.
Lim J; Park Y; Ahn JW; Sim J; Kang SJ; Hwang S; Chun J; Choi H; Kim SH; Chun DH; Sung KS; Kwack K; Cho K
PLoS One; 2021; 16(3):e0247293. PubMed ID: 33690665
[TBL] [Abstract][Full Text] [Related]
16. Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.
Stegh AH; Kesari S; Mahoney JE; Jenq HT; Forloney KL; Protopopov A; Louis DN; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10703-8. PubMed ID: 18669646
[TBL] [Abstract][Full Text] [Related]
17. siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown.
Randeria PS; Seeger MA; Wang XQ; Wilson H; Shipp D; Mirkin CA; Paller AS
Proc Natl Acad Sci U S A; 2015 May; 112(18):5573-8. PubMed ID: 25902507
[TBL] [Abstract][Full Text] [Related]
18. Molecular Evolution of
Draaisma K; Chatzipli A; Taphoorn M; Kerkhof M; Weyerbrock A; Sanson M; Hoeben A; Lukacova S; Lombardi G; Leenstra S; Hanse M; Fleischeuer R; Watts C; McAbee J; Angelopoulos N; Gorlia T; Golfinopoulos V; Kros JM; Verhaak RGW; Bours V; van den Bent MJ; McDermott U; Robe PA; French PJ
J Clin Oncol; 2020 Jan; 38(1):81-99. PubMed ID: 31743054
[TBL] [Abstract][Full Text] [Related]
19. What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator.
Stegh AH; Chin L; Louis DN; DePinho RA
Cell Cycle; 2008 Sep; 7(18):2833-9. PubMed ID: 18769159
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
